Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.94 USD | +5.20% | +1.97% | -9.57% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.57% | 236M | |
+28.54% | 449B | |
+32.84% | 279B | |
+4.37% | 134B | |
+29.26% | 93.1B | |
+6.12% | 91.72B | |
+63.99% | 61.12B | |
+14.10% | 46.14B | |
+24.73% | 37.24B | |
-1.67% | 35.1B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Lake street Adjusts OptimizeRx Price Target to $13 From $18, Maintains Buy Rating